RxDoctor Payments Data

Cynthia Canga Siao, MD

Internal Medicine · Draper, UTNPI 1669497558

Payments from drug & device makers

$2,781in general payments, 2019–2025

Across 150 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$691
  • Boehringer Ingelheim$260
  • Astellas Pharma US Inc$257
  • Novo Nordisk$249
  • Abbott$223
  • Lilly USA, LLC$198
  • plus $904 from 18 others

What the payments were for

  • Food & beverage$2,70197%
  • Education$803%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,781 in reported general payments places this provider in the 80th percentile of 496 internal medicine providers in Utah.

See all internal medicine providers in Utah

Medicare billing

Part B allowed, 2024
$102,709
Medicare patients
274
Services billed
1,225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin56$72,961
EliquisApixaban45$61,833
OzempicSemaglutide32$38,027
XareltoRivaroxaban18$28,377
MounjaroTirzepatide13$21,919
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15$7,004
Omeprazole170$3,068
SymbicortBudesonide/Formoterol Fumarate13$2,938
Levothyroxine Sodium318$2,860
Atorvastatin Calcium358$2,776
SynthroidLevothyroxine Sodium32$2,286
Gabapentin105$2,061
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$2,039
Albuterol Sulfate HfaAlbuterol Sulfate73$1,856
Rosuvastatin Calcium137$1,764

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$260$72,96156 claims
PfizerEliquis$93$61,83345 claims
Novo NordiskOzempic$249$38,02732 claims
Johnson & JohnsonXarelto$87$28,37718 claims
Lilly USA, LLCMounjaro$198$21,91913 claims
GSKAnoro Ellipta$137$7,00415 claims
AstraZenecaSymbicort$52$2,93813 claims
AbbVieSynthroid$691$2,28632 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 496 internal medicine providers in Utah.

Other internal medicine in Draper

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →